Zerlina Dwi Ramadhannisa

Zerlina Dwi Ramadhannisa

Auto-generated profile, based on publicly available information

Zerlina Dwi Ramadhannisa

Department of Biomedical Science, Faculty of Medicine, University of Andalas, Padang, Indonesia

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 June 2024 in Journal of Herbmed Pharmacology
Verified
Journal Article
Open access
PDF file
SKSalsabila Putri Khairani
Salsabila Putri Khairani
KCKevin Nathaniel Cuandra
Kevin Nathaniel Cuandra
ZRZerlina Dwi Ramadhannisa
Zerlina Dwi Ramadhannisa
ARAldi Tamara Rahman
Aldi Tamara Rahman
DADessy Arisanty
Dessy Arisanty
NHNoza Hilbertina
Noza Hilbertina
Introduction: Breast cancer remains a prevalent global malignancy and necessitates a treatment regimen, which is often accompanied by substantial side effects. To address this challenge, alternative therapies with fewer adverse effects are urgently needed. Amomum cardamomum has displayed promising anticancer potential. This study aimed to investigate the impact of A. cardamomum seed on T47D breast cancer cell viability and the ability to induce apoptosis, utilizing in silico and in vitro approaches. Methods: The samples were extracted utilizing the maceration method using ethanol 96% solvent. In addition, the bioactive constituents were identified through phytochemicals and GC/MS analysis. Cell viability was assessed through MTT assay at various concentrations with 24 and 48-hour incubation periods and compared with the control cells. Apoptosis patterns were visualized by Immunofluorescence assay and analyzed utilizing ImageJ software. In silico analyses included three distinct tests, namely pharmacokinetics analysis (ADMET), bioactivity prediction (PASS), and molecular docking. Results: The A. cardamomum seed extract inhibited the growth of the cells with an IC50 value of 97.28 μg/mL in 48 hours of the incubation period. Immunofluorescence assay exhibited that the extract induced apoptosis in over 50% of T47D cells. In silico approaches identified bicyclogermacrene, Germacrene-D, and δ-cadinene as potential JAK3, BRAF v600e, and MMP9 protein inhibitors. These compounds exhibited stronger binding affinities to critical amino acids than control ligands. Conclusion: This research presents compelling evidence that the A. cardamomum extract has anticancer activity against breast cancer by preventing growth and inducing apoptosis.